Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,800
Closed -$3.57M 354
2025
Q2
$3.57M Buy
+12,800
New +$3.63M 0.3% 62
2020
Q3
Sell
-129,000
Closed -$30.4M 79
2020
Q2
$30.4M Buy
+129,000
New +$29.4M 1.35% 13
2019
Q3
Sell
-150,000
Closed -$27.6M 80
2019
Q2
$27.6M Sell
150,000
-693,100
-82% -$124M 1.15% 20
2019
Q1
$160M Buy
+843,100
New +$161M 5.9% 6

Other funds holding AMGN

DLD Asset Management's AMGN Position: Q3 2025 in Review

DLD Asset Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 1,134 shares — an estimated $317K sold.

DLD Asset Management first reported a position in AMGN in Q1 2019 and held it in 2 quarters. The position peaked at $53.2M in Q1 2019. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • DLD Asset Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • DLD Asset Management sold 1,134 Amgen shares in Q3 2025, an estimated $317K.
  • DLD Asset Management first reported a position in Amgen in Q1 2019 and held it in 2 quarters.
  • DLD Asset Management's Amgen position peaked at $53.2M in Q1 2019.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on DLD Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.